Skip to main content
Back to Qiming Venture Partners

Qiming Venture Partners's Biopharma Portfolio

Browse 11 Biopharma companies funded by Qiming Venture Partners. See funding amounts, founder contacts, and investment details.

Biopharma Companies
11
Total Funding in Biopharma
$650.0M

Biopharma Portfolio Companies (11)

Export
BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Foster City, United States
September 2025
$63.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedicalTherapeutics

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Woburn, United States
December 2025
$110.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

CSR Biotech is a biological research company that provides cell imaging and data processing services.

Haidian, China
March 2026
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaHealth CareMedical

QL Biopharma focuses on developing innovative drugs and premium me-too drugs targeting metabolic diseases.

Changping, China
March 2026
$72.8M
Series C

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiopharmaBiotechnologyGeneticsNanotechnologyPharmaceuticalTherapeutics

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

Brisbane, United States
February 2026
$60.0M
Series B

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments.

Minhang, China
January 2026
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceutical

Zenitar is a biomedical technology company engaged in innovative drug research and industrialization processes.

Chengdu, China
January 2026
$86.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Brise Pharma operates in the scientific research and technical service industry.

Shanghai, China
November 2025
$28.1M
Series A

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedicalPharmaceuticalProduct ResearchTherapeutics

Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.

Shanghai, China
August 2025
$131.0M
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Tianchen Biotechnology is a biotech company that specializes in the development and sales of ophthalmology-related medical products.

Tianjin, China
June 2025
$27.8M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyMedical

Yuyao Bio is an innovative drug research and development company.

Shanghai, China
April 2025
$71.3M
Series A

Founder Contacts

19,000+ verified contacts

Explore Qiming Venture Partners's Full Portfolio

View all companies funded by Qiming Venture Partners across every industry and funding stage.

View Full Qiming Venture Partners Portfolio